FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jordi Bruix

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Physiology

Disease Progression

Anatomy

Livers

Co-author Network

Publications

TOP 3
Daniela Sia; Manel Sole; Barbara Tabak; Swan N Thung; Victoria Tovar; Augusto Villanueva; Samuel Waxman; Vincenzo Mazzaferro; Judit Peix; Sasan Roayaie; Myron E Schwartz; Clara Alsinet-Armengol; Rameen Beroukhim; Jordi Bruix; Helena Cornella; Christian Cotsoglou; Jian-Bing Fan; Joana Ferrer; Josep Fuster; Juan Carlos Garcia-Valdecasas; Yujin Hoshida; Brandy Klotzle; Josep M Llovet
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.
Jordi Bruix; Antonio Craxi; Peter R Galle; Guido Gerken; Michel Beaugrand; Luigi Bolondi; Jorge A Marrero; Vincenzo Mazzaferro; Marius Moscovici; Andrea Nadel; Camillo Porta; Jean-Luc Raoul; Angelo Sangiovanni; Armando Santoro; Michael Shan; Morris Sherman; Dimitris Voliotis; Josep M Llovet
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.
Silvia Tremosini; Ramón Vilana; Carmen Ayuso; Luis Bianchi; Loreto Boix; Alejandro Forner; Maria Reig; Jordi Rimola; Carlos Rodríguez-Lope; Manel Solé; Jordi Bruix
Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jordi Bruix (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Daniela Sia; Manel Sole; Barbara Tabak; Swan N Thung; Victoria Tovar; Augusto Villanueva; Samuel Waxman; Vincenzo Mazzaferro; Judit Peix; Sasan Roayaie; Myron E Schwartz; Clara Alsinet-Armengol; Rameen Beroukhim; Jordi Bruix; Helena Cornella; Christian Cotsoglou; Jian-Bing Fan; Joana Ferrer; Josep Fuster; Juan Carlos Garcia-Valdecasas; Yujin Hoshida; Brandy Klotzle; Josep M Llovet
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.
Gastroenterology 2013;144(4):829-40.
2012: Jordi Bruix; Antonio Craxi; Peter R Galle; Guido Gerken; Michel Beaugrand; Luigi Bolondi; Jorge A Marrero; Vincenzo Mazzaferro; Marius Moscovici; Andrea Nadel; Camillo Porta; Jean-Luc Raoul; Angelo Sangiovanni; Armando Santoro; Michael Shan; Morris Sherman; Dimitris Voliotis; Josep M Llovet
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.
Journal of hepatology 2012;57(4):821-9.
2012: Silvia Tremosini; Ramón Vilana; Carmen Ayuso; Luis Bianchi; Loreto Boix; Alejandro Forner; Maria Reig; Jordi Rimola; Carlos Rodríguez-Lope; Manel Solé; Jordi Bruix
Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.
Gut 2012;61(10):1481-7.
2012: Anja Lachenmayer; Clara Alsinet-Armengol; Jordi Barretina; Jordi Bruix; Laia Cabellos; Scott L Friedman; Yujin Hoshida; Vincenzo Mazzaferro; Beatriz Minguez; Philippa Newell; Radoslav Savic; Myron Schwartz; Swan Thung; Sara Toffanin; Hung-Wen Tsai; Augusto Villanueva; Stephen C Ward; Josep M Llovet
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(18):4997-5007.
2012: Marta Burrel; Alejandro Forner; Josep M Llovet; María Isabel Real; María Reig; Silvia Tremosini; Carlos Rodríguez de Lope; Carmen Ayuso; Marta Barrufet; Jordi Bruix
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.
Journal of hepatology 2012;56(6):1330-5.
2012: Jordi Rimola; Carlos Rodríguez-Lope; Manel Solé; Silvia Tremosini; Ramón Vilana; Carmen Ayuso; Luis Bianchi; Alejandro Forner; Maria Reig; Jordi Bruix
Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI.
Journal of hepatology 2012;56(6):1317-23.
2012: Jean-Luc Raoul; Sergio Ricci; Hans Scherübl; Max E Scheulen; Morris Sherman; Dimitris Voliotis; Jordi Bruix; Sophie Dominguez; Georgios Germanidis; Tim F Greten; Philip Hilgard; Vincenzo Mazzaferro; Marius Moscovici; Andrea Nadel; Josep M Llovet
Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.
Journal of hepatology 2012;56(5):1080-8.
2012: Josep M Llovet; Gerold Meinhardt; Carol E A Peña; Michael Shan; Jordi Bruix; Chetan Lathia
Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(8):2290-300.
2012: Alejandro Forner; Josep M Llovet; Jordi Bruix
Hepatocellular carcinoma.
Lancet 2012;379(9822):1245-55.
2012: Carlos Rodríguez de Lope; Alejandro Forner; María Reig; Silvia Tremosini; Jordi Bruix
Management of HCC.
Journal of hepatology 2012;56 Suppl 1():S75-87.
2011: Jordi Bruix; Marta Burrel; Alejandro Forner; Maria Reig; Jordi Rimola; Ramón Vilana; Carmen Ayuso
Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques.
Hepatology (Baltimore, Md.) 2011;54(6):2238-44.
2011: Beatriz Mínguez; Sasan Roayaie; Radoslav Savic; Myron Schwartz; Daniela Sia; Swan Thung; Sara Toffanin; Augusto Villanueva; Craig April; Jordi Bruix; Laia Cabellos; Jian-Bing Fan; Scott L Friedman; Yujin Hoshida; Anja Lachenmayer; John Mandeli; Vincenzo Mazzaferro; Josep M Llovet
Gene-expression signature of vascular invasion in hepatocellular carcinoma.
Journal of hepatology 2011;55(6):1325-31.
2011: Maria Reig; Jordi Bruix
The search for an effective partner for sorafenib: the failure of doxorubicin.
Gastroenterology 2011;140(5):1687-8.
2011: Sara Toffanin; Yujin Hoshida; Anja Lachenmayer; Augusto Villanueva; Laia Cabellos; Beatriz Minguez; Radoslav Savic; Stephen C Ward; Swan Thung; Derek Chiang; Clara Alsinet-Armengol; Victoria Tovar; Sasan Roayaie; Myron Schwartz; Jordi Bruix; Samuel Waxman; Scott L Friedman; Todd Golub; Vincenzo Mazzaferro; Josep M Llovet
MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a.
Gastroenterology 2011;140(5):1618-28.e16.
2011: Augusto Villanueva; Yujin Hoshida; Carlo Battiston; Victoria Tovar; Daniela Sia; Clara Alsinet-Armengol; Helena Cornella; Arthur Liberzon; Masahiro Kobayashi; Hiromitsu Kumada; Swan N Thung; Jordi Bruix; Philippa Newell; Craig April; Jian-Bing Fan; Sasan Roayaie; Vincenzo Mazzaferro; Myron E Schwartz; Josep M Llovet
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.
Gastroenterology 2011;140(5):1501-12.e2.
2010: Alejandro Forner; Carlos Rodríguez De Lope; María Reig; Jordi Bruix
[Treatment of advanced hepatocellular carcinoma].
Gastroenterología y hepatología 2010;33(6):461-8.
2010: Victoria Tovar; Clara Alsinet-Armengol; Augusto Villanueva; Yujin Hoshida; Derek Chiang; Manel Solé; Swan Thung; Susana Moyano; Sara Toffanin; Beatriz Mínguez; Laia Cabellos; Judit Peix; Myron Schwartz; Vincenzo Mazzaferro; Jordi Bruix; Josep M Llovet
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.
Journal of hepatology 2010;52(4):550-9.
2010: Jordi Bruix; Josep M Llovet
Two decades of advances in hepatocellular carcinoma research.
Seminars in liver disease 2010;30(1):1-2.
2009: Jordi Bruix; Keith Lindor
The need for novel and interesting data in liver cancer research.
Hepatology (Baltimore, Md.) 2009;50(6):1690-1.
2009: Pippa Newell; Sara Toffanin; Augusto Villanueva; Derek Chiang; Beatriz Minguez; Laia Cabellos; Radoslav Savic; Yujin Hoshida; Kiat Hon Lim; Pedro Melgar-Lesmes; Steven Yea; Judit Peix; Kemal Deniz; M Isabel Fiel; Swan Thung; Clara Alsinet-Armengol; Victoria Tovar; Vincenzo Mazzaferro; Jordi Bruix; Sasan Roayaie; Myron Schwartz; Scott L Friedman; Josep M Llovet
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
Journal of hepatology 2009;51(4):725-33.
2009: Mercedes Fernández; David Semela; Jordi Bruix; Isabelle Colle; Massimo Pinzani; Jaume Bosch
Angiogenesis in liver disease.
Journal of hepatology 2009;50(3):604-20.
2009: Alejandro Forner; Carmen Ayuso; María Isabel Real; Javier Sastre; Ricardo Robles; Bruno Sangro; María Varela; Manuel De la Mata; María Buti; Luis Marti-Bonmati; Concepció Bru; Josep Tabernero; Josep M Llovet; Jordi Bruix
[Diagnosis and treatment of hepatocellular carcinoma].
Medicina clínica 2009;132(7):272-87.
2008: Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
The New England journal of medicine 2008;359(19):1995-2004.
2008: Josep M Llovet; Jordi Bruix
Molecular targeted therapies in hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 2008;48(4):1312-27.
2008: Derek Chiang; Augusto Villanueva; Yujin Hoshida; Judit Peix; Philippa Newell; Beatriz Minguez; Amanda C LeBlanc; Diana J Donovan; Swan N Thung; Manel Solé; Victoria Tovar; Clara Alsinet-Armengol; Alex H Ramos; Jordi Barretina; Sasan Roayaie; Myron Schwartz; Samuel Waxman; Jordi Bruix; Vincenzo Mazzaferro; Azra H Ligon; Vesna Najfeld; Scott L Friedman; William R Sellers; Matthew Meyerson; Josep M Llovet
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
Cancer research 2008;68(16):6779-88.
2008: Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Sorafenib in advanced hepatocellular carcinoma.
The New England journal of medicine 2008;359(4):378-90.
2008: Josep M Llovet; Adrian M Di Bisceglie; Jordi Bruix; Barnett S Kramer; Riccardo Lencioni; Andrew X Zhu; Morris Sherman; Myron Schwartz; Michael Lotze; Jayant Talwalkar; Gregory J Gores
Design and endpoints of clinical trials in hepatocellular carcinoma.
Journal of the National Cancer Institute 2008;100(10):698-711.
2008: Jordi Bruix
Liver cancer: An evolving challenge reaching research maturity.
Hepatology (Baltimore, Md.) 2008;47(4):1103-4.
2008: Josep M Llovet; Jordi Bruix
Novel advancements in the management of hepatocellular carcinoma in 2008.
Journal of hepatology 2008;48 Suppl 1():S20-37.
2008: Alejandro Forner; Jordi Bruix
Locoregional treatment for hepatocellular carcinoma: From clinical exploration to robust clinical data, changing standards of care.
Hepatology (Baltimore, Md.) 2008;47(1):5-7.
2008: Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 2008;47(1):97-104.
2007: Alejandro Forner; Maria Isabel Real; María Varela; Jordi Bruix
Transarterial chemoembolization for patients with hepatocellular carcinoma.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37 Suppl 2():S230-7.
2007: María Varela; Maria Isabel Real; Marta Burrel; Alejandro Forner; Margarita Sala; Mercé Brunet; Carmen Ayuso; Lluis Castells; Xavier Montañá; Josep M Llovet; Jordi Bruix
Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
Journal of hepatology 2007;46(3):474-81.
2006: Alejandro Forner; Amelia J Hessheimer; M Isabel Real; Jordi Bruix
Treatment of hepatocellular carcinoma.
Critical reviews in oncology/hematology 2006;60(2):89-98.
2006: Ramón Vilana; Luis Bianchi; M Varela; Carlos Nicolau; M Sánchez; Carmen Ayuso; M García; Margarita Sala; Josep M Llovet; Jordi Bruix; Concepció Bru
Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?
European radiology 2006;16(11):2454-62.
2006: María Varela; Alejandro Forner; Jordi Bruix
Diagnosis and staging of hepatocellular carcinoma prior to transplantation: expertise or failure.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006;12(10):1445-7.
2006: María Varela; William Sanchez; Jordi Bruix; Gregory J Gores
Hepatocellular carcinoma in the setting of liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006;12(7):1028-36.
2006: Sharon L Lederer; Kathie-Anne Walters; Sean C Proll; Bryan Paeper; Shahar Robinzon; Loreto Boix; Nelson Fausto; Jordi Bruix; Michael G Katze
Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis.
Virology journal 2006;3():98.
2005: Antoni Rimola; Josep M Llovet; Miquel Navasa; Jordi Bruix; María-Carlota Londoño; Josep Fuster; Juan Carlos García-Valdecasas
Applicability of adult-to-adult living donor liver transplantation.
Journal of hepatology 2005;43(1):104-9.
2005: M Sala; María Varela; Alejandro Forner; Jordi Bruix
[Early diagnosis of liver cancer].
Gastroenterología y hepatología 2005;28(5):292-7.
2005: Margarita Sala; Alejandro Forner; María Varela; Jordi Bruix
Prognostic prediction in patients with hepatocellular carcinoma.
Seminars in liver disease 2005;25(2):171-80.
2004: Margarita Sala; Josep M Llovet; Ramón Vilana; Lluís Bianchi; Manel Solé; Carmen Ayuso; Concepció Brú; Jordi Bruix
Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 2004;40(6):1352-60.
2004: Juan Ramón Ayuso; Carmen Ayuso; Ernest Bombuy; Carmen de Juan; Josep M Llovet; Teresa M De Caralt; Marcel Sánchez; Mario Pagés; Jordi Bruix; Juan Carlos García-Valdecasas
Preoperative evaluation of biliary anatomy in adult live liver donors with volumetric mangafodipir trisodium enhanced magnetic resonance cholangiography.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004;10(11):1391-7.
2004: Margarita Sala; Josep Fuster; Josep M Llovet; Miquel Navasa; Manel Solé; María Varela; Fernando Pons; Antoni Rimola; Juan Carlos García-Valdecasas; Concepció Brú; Jordi Bruix
High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004;10(10):1294-300.
2004: Carolina Armengol; Gemma Tarafa; Loreto Boix; Manel Solé; Rosa Queralt; Dolors Costa; Oriol Bachs; Jordi Bruix; Gabriel Capellá
Orthotopic implantation of human hepatocellular carcinoma in mice: analysis of tumor progression and establishment of the BCLC-9 cell line.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):2150-7.
2004: Josep Fuster; Josep M Llovet; Juan C Garcia-Valdecasas; Luis Grande; Constantino Fondevila; Ramón Vilana; Jordi Palacin; Jeanine Tabet; Joana Ferrer; Jordi Bruix; Josep Visa
Abdominal drainage after liver resection for hepatocellular carcinoma in cirrhotic patients: a randomized controlled study.
Hepato-gastroenterology 2004;51(56):536-40.
2004: Jordi Bruix; Loreto Boix; Margarita Sala; Josep M Llovet
Focus on hepatocellular carcinoma.
Cancer cell 2004;5(3):215-9.
2003: Josep M Llovet; Andrew Burroughs; Jordi Bruix
Hepatocellular carcinoma.
Lancet 2003;362(9399):1907-17.
2003: Maria W Smith; Zhaoxia N Yue; Marcus J Korth; Hao A Do; Loreto Boix; Nelson Fausto; Jordi Bruix; Robert L Carithers; Michael G Katze
Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers.
Hepatology (Baltimore, Md.) 2003;38(6):1458-67.
2003: Marta Burrel; Josep M Llovet; Carmen Ayuso; Carmela Iglesias; Margarita Sala; Rosa Miquel; Teresa Caralt; Juan Ramón Ayuso; Manel Solé; Marcelo Sanchez; Concepció Brú; Jordi Bruix
MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation.
Hepatology (Baltimore, Md.) 2003;38(4):1034-42.
2003: María Varela; Javier Fernández; Miquel Navasa; Jordi Bruix
Pseudotumoral hepatic tuberculosis.
Journal of hepatology 2003;39(4):654.
2003: Carolina Armengol; Loreto Boix; Oriol Bachs; Manel Solé; Josep Fuster; Margarita Sala; Josep M Llovet; Juan Rodés; Jordi Bruix
p27(Kip1) is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma.
Journal of hepatology 2003;38(5):591-7.
2003: María Varela; Margarita Sala; Josep M Llovet; Jordi Bruix
Treatment of hepatocellular carcinoma: is there an optimal strategy?
Cancer treatment reviews 2003;29(2):99-104.
2003: Ramón Vilana; Josep M Llovet; Luis Bianchi; Marcelo Sanchez; Mario Pagés; Margarita Sala; Rosa Gilabert; Carlos Nicolau; Angeles Garcia; Carmen Ayuso; Jordi Bruix; Concepció Bru
Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
Journal of clinical ultrasound : JCU 2003;31(3):119-28.
2003: Maria W Smith; Zhaoxia N Yue; Gary K Geiss; Natalya Y Sadovnikova; Victoria S Carter; Loreto Boix; Catherine Lazaro; Gary B Rosenberg; Roger Bumgarner; Nelson Fausto; Jordi Bruix; Michael G Katze
Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma.
Cancer research 2003;63(4):859-64.
2003: Josep M Llovet; Jordi Bruix
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival.
Hepatology (Baltimore, Md.) 2003;37(2):429-42.
2003: Jordi Bruix; Josep M Llovet
Hepatitis B virus and hepatocellular carcinoma.
Journal of hepatology 2003;39 Suppl 1():S59-63.
2002: Xavier Forns; José M Sánchez-Tapias; Albert Pares; Josep M Llovet; Jordi Bruix; Juan Rodés
Expected developments in hepatology.
Best practice & research. Clinical gastroenterology 2002;16(6):957-70.
2002: M Sala; Josep M Llovet; Jordi Bruix
[Considerations of the Barcelona Conference on the diagnosis and treatment of hepatocellular carcinoma].
Gastroenterología y hepatología 2002;25(9):570-4.
2002: Josep M Llovet; Maria Isabel Real; Xavier Montaña; Ramon Planas; Susanna Coll; John Aponte; Carmen Ayuso; Margarita Sala; Jordi Muchart; Ricard Solà; Juan Rodés; Jordi Bruix
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.
Lancet 2002;359(9319):1734-9.
2002: Jordi Bruix; Josep M Llovet
Prognostic prediction and treatment strategy in hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 2002;35(3):519-24.
2002: J M Llovet; X Mas; J J Aponte; J Fuster; M Navasa; E Christensen; J Rodés; Jordi Bruix
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation.
Gut 2002;50(1):123-8.
2001: Jordi Bruix; M Sherman; Josep M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; Juan Rodés
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.
Journal of hepatology 2001;35(3):421-30.
2001: Mireia Giménez-Barcons; Sandra Franco; Y Suárez; Xavier Forns; Sergi Ampurdanès; FRANCESC PUIG-BASAGOITI; Alberto Sánchez-Fueyo; J M Barrera; J M Llovet; Jordi Bruix; José M Sánchez-Tapias; Juan Rodés; Juan Carlos Saiz
High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.
Hepatology (Baltimore, Md.) 2001;34(1):158-67.
2001: Josep M Llovet; Ramón Vilana; Concepció Brú; Lluís Bianchi; J M Salmeron; Loreto Boix; Sergi Ganau; Margarita Sala; M Pagès; Carmen Ayuso; Manel Solé; Juan Rodés; Jordi Bruix
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 2001;33(5):1124-9.
2000: J M Llovet; Jordi Bruix
Early diagnosis and treatment of hepatocellular carcinoma.
Baillière's best practice & research. Clinical gastroenterology 2000;14(6):991-1008.
2000: Josep M Llovet; Eduardo Moitinho; Margarita Sala; Ramón Bataller; P Rodríguez-Iglesias; A Castells; Javier Fernández; Ramon Planas; Miquel Navasa; Jordi Bruix; Juan Rodés
Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis.
Journal of hepatology 2000;33(3):423-9.
2000: Josep M Llovet; Margarita Sala; Lluis Castells; Y Suarez; Ramón Vilana; L Bianchi; Carmen Ayuso; Víctor Vargas; Juan Rodés; Jordi Bruix
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 2000;31(1):54-8.
1999: Jordi Bruix; Josep M Llovet
Locoregional treatments for hepatocellular carcinoma.
Baillière's best practice & research. Clinical gastroenterology 1999;13(4):611-22.
1999: J M Llovet; J Fuster; Jordi Bruix
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.
Hepatology (Baltimore, Md.) 1999;30(6):1434-40.
1999: Y Suarez; M Sala; J M Llovet; Jordi Bruix
Diagnosis and treatment of hepatocellular carcinoma.
Acta gastro-enterologica Belgica 1999;62(4):410-4.
1999: Mireia Giménez-Barcons; Xavier Forns; Sergi Ampurdanés; Magda Guilera; M Soler; C Soguero; Alberto Sánchez-Fueyo; A Mas; Jordi Bruix; José M Sánchez-Tapias; Juan Rodés; Juan Carlos Saiz
Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases.
Journal of hepatology 1999;30(6):1028-34.
1999: J M Llovet; Concepció Brú; Jordi Bruix
Prognosis of hepatocellular carcinoma: the BCLC staging classification.
Seminars in liver disease 1999;19(3):329-38.
1999: Josep M Llovet; J Bustamante; A Castells; Ramón Vilana; M del C Ayuso; M Sala; Concepció Brú; J Rodés; Jordi Bruix
Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.
Hepatology (Baltimore, Md.) 1999;29(1):62-7.
1998: E M Webber; Jordi Bruix; Robert H Pierce; Nelson Fausto
Tumor necrosis factor primes hepatocytes for DNA replication in the rat.
Hepatology (Baltimore, Md.) 1998;28(5):1226-34.
1998: C Bréchot; F Jaffredo; D Lagorce; G Gerken; K Meyer zum Büschenfelde; A Papakonstontinou; S Hadziyannis; R Romeo; M Colombo; Juan Rodes; Jordi Bruix; R Williams; Nikolai Naoumov
Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.
Journal of hepatology 1998;29(2):173-83.
1998: Jordi Bruix; Josep M Llovet; A Castells; Xavier Montañá; Concepció Brú; M C Ayuso; Ramón Vilana; J Rodés
Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.
Hepatology (Baltimore, Md.) 1998;27(6):1578-83.
1998: Josep M Llovet; Jordi Bruix; Josep Fuster; A Castells; Juan Carlos Garcia-Valdecasas; L Grande; A Franca; Concepció Brú; Miquel Navasa; M C Ayuso; M Solé; M I Real; Ramón Vilana; Antoni Rimola; J Visa; J Rodés
Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power.
Hepatology (Baltimore, Md.) 1998;27(6):1572-7.
1998: Alberto Leivas; Wladimiro Jiménez; Jordi Bruix; Loreto Boix; J Bosch; Vicente Arroyo; Francisca Rivera; Juan Rodés
Gene expression of endothelin-1 and ET(A) and ET(B) receptors in human cirrhosis: relationship with hepatic hemodynamics.
Journal of vascular research 1998;35(3):186-93.
1998: Magda Guilera; Juan-Carlos Sáiz; FX López-Labrador; Eva Olmedo; Sergi Ampurdanés; Xavier Forns; Jordi Bruix; Albert Pares; José M Sánchez-Tapias; M Teresa Jiménez de Anta; Juan Rodés
Hepatitis G virus infection in chronic liver disease.
Gut 1998;42(1):107-11.
1997: FX López-Labrador; Sergi Ampurdanés; Xavier Forns; A Castells; Juan-Carlos Sáiz; Josep Costa; Jordi Bruix; José M Sánchez-Tapias; M Teresa Jiménez de Anta; Juan Rodés
Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma.
Journal of hepatology 1997;27(6):959-65.
1996: Jordi Bruix; A Castells; Jaime Bosch; Faust Feu; Josep Fuster; J C Garcia-Pagan; J Visa; Concepció Bru; Juan Rodés
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.
Gastroenterology 1996;111(4):1018-22.
1996: J I Elizalde; A Castells; Ramon Planas; M P Rodríguez-Iglesias; Jordi Bruix; Concepció Brú; Joan Saló; J Boix; Miquel A Gassull; J Terés; J Rodés
[Prevalence of hepatocellular carcinoma in cirrhotic patients with with portosystemic shunt. Cohort analysis].
Gastroenterología y hepatología 1996;19(4):189-93.
1995: A Castells; Jordi Bruix; Concepció Brú; C Ayuso; M Roca; L Boix; Ramón Vilana; Juan Rodés
Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients.
Gastroenterology 1995;109(3):917-22.
1995: L Boix; A Castells; Jordi Bruix; M Solé; Concepció Brú; Josep Fuster; Francisca Rivera; Juan Rodés
Androgen receptors in hepatocellular carcinoma and surrounding liver: relationship with tumor size and recurrence rate after surgical resection.
Journal of hepatology 1995;22(6):616-22.
1995: A Castells; Jordi Bruix; C Ayuso; Concepció Brú; X Montanyà; L Boix; J Rodès
Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever.
Journal of hepatology 1995;22(4):410-5.
1994: Jaime Bosch; Jordi Bruix; A Mas; Miquel Navasa; Juan Rodés
Rolling review: the treatment of major complications of cirrhosis.
Alimentary pharmacology & therapeutics 1994;8(6):639-57.
1994: Jordi Bruix; A Castells; X Montanyà; Xavier Calvet; Concepció Brú; C Ayuso; L Jover; L García; Ramón Vilana; L Boix
Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials.
Hepatology (Baltimore, Md.) 1994;20(3):643-50.
1994: L Boix; Jordi Bruix; E Campo; M Sole; A Castells; Josep Fuster; Francisca Rivera; A Cardesa; Juan Rodes
nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma.
Gastroenterology 1994;107(2):486-91.
1994: L Boix; Jose Luis Rosa; Francesc Ventura; A Castells; Jordi Bruix; Juan Rodés; Ramon Bartrons
c-met mRNA overexpression in human hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 1994;19(1):88-91.
1993: A Castells; Jordi Bruix; Concepció Bru; Josep Fuster; Ramón Vilana; Miquel Navasa; C Ayuso; L Boix; Josep Visa; Juan Rodés
Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection.
Hepatology (Baltimore, Md.) 1993;18(5):1121-6.
1993: Ramón Vilana; Concepció Bru; Jordi Bruix; A Castells; M Sole; Juan Rodes
Fine-needle aspiration biopsy of portal vein thrombus: value in detecting malignant thrombosis.
AJR. American journal of roentgenology 1993;160(6):1285-7.
1993: L Boix; Jordi Bruix; A Castells; Josep Fuster; Concepció Bru; Josep Visa; Francisca Rivera; Juan Rodes
Sex hormone receptors in hepatocellular carcinoma. Is there a rationale for hormonal treatment?
Journal of hepatology 1993;17(2):187-91.
1992: C Ayuso; Patricio Luburich; Ramón Vilana; Concepció Bru; Jordi Bruix
Calcifications in the portal venous system: comparison of plain films, sonography, and CT.
AJR. American journal of roentgenology 1992;159(2):321-3.
1992: Ramón Vilana; Jordi Bruix; Concepció Bru; C Ayuso; M Solé; Juan Rodés
Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 1992;16(2):353-7.
1992: Jordi Bruix; Isabel Cirera; Xavier Calvet; Josep Fuster; Concepció Bru; C Ayuso; Ramón Vilana; L Boix; Josep Visa; Juan Rodés
Surgical resection and survival in Western patients with hepatocellular carcinoma.
Journal of hepatology 1992;15(3):350-5.
1991: Xavier Calvet; Jordi Bruix; Jaime Bosch; Juan Rodes
Portal pressure in patients with exudative ascites in the course of acute hepatitis B.
Liver 1991;11(4):206-10.
1991: Rafael Molina; Xavier Filella; Jordi Bruix; P Mengual; Jaime Bosch; Xavier Calvet; J Jo; Antonio M Ballesta
Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases.
Clinical chemistry 1991;37(8):1379-83.
1991: E Ponz; Juan Carlos García-Pagán; M Bruguera; Jordi Bruix; Juan Rodés
Hepatic fibrin-ring granulomas in a patient with hepatitis A.
Gastroenterology 1991;100(1):268-70.
1990: Xavier Calvet; Jordi Bruix; P Ginés; Concepció Bru; M Solé; Ramón Vilana; Juan Rodés
Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients.
Hepatology (Baltimore, Md.) 1990;12(4 Pt 1):753-60.
1990: M V Mayans; Xavier Calvet; Jordi Bruix; M Bruguera; J Costa; J Estève; F X Bosch; Concepció Bru; J Rodés
Risk factors for hepatocellular carcinoma in Catalonia, Spain.
International journal of cancer. Journal international du cancer 1990;46(3):378-81.
1990: José M Sánchez-Tapias; J M Barrera; Josep Costa; M G Ercilla; Albert Pares; L Comalrrena; F Soley; Jordi Bruix; Xavier Calvet; M P Gil
Hepatitis C virus infection in patients with nonalcoholic chronic liver disease.
Annals of internal medicine 1990;112(12):921-4.
1990: Angels Ginès; Josep Llach; Xavier Calvet; Jordi Bruix; Vicente Arroyo; Juan Rodés
Neck "ascites" after peritoneovenous shunt.
Journal of clinical gastroenterology 1990;12(3):347-9.
1990: Jordi Bruix; A Castells; Xavier Calvet; Faust Feu; Concepció Bru; M Solé; M Bruguera; J Rodés
Diarrhea as a presenting symptom of hepatocellular carcinoma.
Digestive diseases and sciences 1990;35(6):681-5.
1990: Xavier Calvet; Jordi Bruix; Concepció Brú; P Ginés; Ramón Vilana; M Solé; M C Ayuso; M Bruguera; Juan Rodes
Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases.
Journal of hepatology 1990;10(3):311-7.
1989: Concepció Bru; A Maroto; Jordi Bruix; R Faus; L Bianchi; Xavier Calvet; C Ayuso; Ramón Vilana; Rosa Gilabert; Juan Rodés
Diagnostic accuracy of fine-needle aspiration biopsy in patients with hepatocellular carcinoma.
Digestive diseases and sciences 1989;34(11):1765-9.
1989: Jordi Bruix; J M Barrera; Xavier Calvet; G Ercilla; Josep Costa; J M Sanchez-Tapias; M Ventura; M Vall; M Bruguera; Concepció Bru
Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.
Lancet 1989;2(8670):1004-6.
1989: R Mastai; Jaime Bosch; Jordi Bruix; Miquel Navasa; D Kravetz; Juan Rodés
Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1989;10(3):269-72.
1989: Antonio M Ballesta; Xavier Calvet; Xavier Filella; Jordi Bruix; C Bru; R Molina; Juan Rodes
Alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
The Journal of nuclear medicine and allied sciences 1989;33(3 Suppl):39-41.
1989: J Rigau; Jaime Bosch; Josep Bordas; Miquel Navasa; R Mastai; D Kravetz; Jordi Bruix; Faust Feu; Juan Rodés
Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage.
Gastroenterology 1989;96(3):873-80.
1988: Xavier Calvet; Francesca Pons; Jordi Bruix; Concepció Bru; Francisco Lomeña; R Herranz; M Brugera; R Faus; Juan Rodes
Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(12):1916-20.
1988: Francesca Pons; Francisco Lomeña; Xavier Calvet; Jordi Bruix; Ana M Catafau; A Ginés; R Herranz; Javier Setoain
Uptake of technetium-99m DISIDA by bone metastasis from a hepatoma.
Clinical nuclear medicine 1988;13(4):280-2.
1987: M A Ginés; E Saperas; Jordi Bruix; J C Paré; P Ginés; J L Pomar; J Rodés
[Intracardiac thrombosis, bacterial endocarditis and pulmonary thromboembolism as a complication of peritoneovenous shunt].
Medicina clínica 1987;89(1):22-4.
1987: R Mastai; Jaime Bosch; Miquel Navasa; D Kravetz; Jordi Bruix; C Viola; Juan Rodés
Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
Journal of hepatology 1987;4(1):71-9.
1986: R Mastai; L Grande; Jaime Bosch; Jordi Bruix; J Rigau; D Kravetz; Miquel Navasa; C Pera; Juan Rodés
Effects of metoclopramide and domperidone on azygos venous blood flow in patients with cirrhosis and portal hypertension.
Hepatology (Baltimore, Md.) 1986;6(6):1244-7.
1985: Jordi Bruix; Jaime Bosch; D Kravetz; R Mastai; Juan Rodés
Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver.
Gastroenterology 1985;88(2):430-5.
1985: Jaime Bosch; R Mastai; D Kravetz; Jordi Bruix; J Rigau; Juan Rodés
Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlations in 100 patients.
Journal of hepatology 1985;1(2):125-39.
1984: Jaime Bosch; R Masti; D Kravetz; Jordi Bruix; J Gaya; J Rigau; Juan Rodes
Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis.
Hepatology (Baltimore, Md.) 1984;4(6):1200-5.
1984: D Kravetz; J Bosch; J Terés; Jordi Bruix; A Rimola; J Rodés
Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage.
Hepatology (Baltimore, Md.) 1984;4(3):442-6.
1984: D Kravetz; Jordi Bruix; J Bosch
[Pharmacological treatment of digestive hemorrhage due to the rupture of esophageal varices].
Acta gastroenterologica Latinoamericana 1984;14(2):165-70.
1982: R J Groszmann; D Kravetz; J Bosch; M Glickman; Jordi Bruix; J Bredfeldt; H O Conn; Juan Rodes; E H Storer
Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
Hepatology (Baltimore, Md.) 1982;2(6):757-62.